Evidence map›Paper›PMID 34152816›Full record

ArticleAntimicrobial agents and chemotherapy2021

Luana Pereira Borba-Santos, Thayná Lopes Barreto, Taissa Vila, Kung Darh Chi, Fabiana Dos Santos Monti, Marconi Rodrigues de Farias, Daniela S Alviano, Celuta S Alviano, Débora O Futuro, Vitor Ferreira and 3 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Silencing ofJournal of fungi (Basel, Switzerland) · 2025
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Journal of fungi (Basel, Switzerland) · 2023
    Article
  9. Journal of fungi (Basel, Switzerland) · 2023
    Review
  10. Silencing ofJournal of fungi (Basel, Switzerland) · 2022
    Article
  11. Review
  12. Current Models to Study theFrontiers in fungal biology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Luana Pereira Borba-SantosLaboratory of Fungal Cell Biology, Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeirogrid.8536.8, Rio de Janeiro, Brazil.
Thayná Lopes BarretoLaboratory of Antifungal Chemotherapy, Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Taissa VilaLaboratory of Fungal Cell Biology, Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeirogrid.8536.8, Rio de Janeiro, Brazil.
Kung Darh ChiPostgraduate Program in Animal Science, School of Life Sciences, Pontifícia Universidade Católica do Paranágrid.412522.2, Curitiba, Paraná, Brazil.
Fabiana Dos Santos MontiPostgraduate Program in Animal Science, School of Life Sciences, Pontifícia Universidade Católica do Paranágrid.412522.2, Curitiba, Paraná, Brazil.
Marconi Rodrigues de FariasPostgraduate Program in Animal Science, School of Life Sciences, Pontifícia Universidade Católica do Paranágrid.412522.2, Curitiba, Paraná, Brazil.
Daniela S AlvianoLaboratory of Microorganism Structure, Department of General Microbiology, Institute of Microbiology Paulo de Góes, Federal University of Rio de Janeirogrid.8536.8, Rio de Janeiro, Brazil.
Celuta S AlvianoLaboratory of Microorganism Structure, Department of General Microbiology, Institute of Microbiology Paulo de Góes, Federal University of Rio de Janeirogrid.8536.8, Rio de Janeiro, Brazil.
Débora O FuturoPharmaceutical Technology Department, Faculty of Pharmacy, Fluminense Federal Universitygrid.411173.1, Niterói, Rio de Janeiro, Brazil.
Vitor FerreiraPharmaceutical Technology Department, Faculty of Pharmacy, Fluminense Federal Universitygrid.411173.1, Niterói, Rio de Janeiro, Brazil.
Wanderley de SouzaLaboratory of Cellular Ultrastructure Hertha Meyer, Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeirogrid.8536.8, Rio de Janeiro, Brazil.
Kelly IshidaLaboratory of Antifungal Chemotherapy, Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Sonia RozentalLaboratory of Fungal Cell Biology, Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeirogrid.8536.8, Rio de Janeiro, Brazil.
Universidade Federal do Rio de Janeiro · BRPontifícia Universidade Católica do Paraná · BRUniversidade de São Paulo · BRUniversidade Federal Fluminense · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sporotrichosis has become an important zoonosis in Brazil, and

Indexed as

SporothrixSporotrichosisAnimalsAntifungal AgentsCatsMicrobial Sensitivity TestsNaphthoquinonesAntifungal AgentsbuparvaquoneNaphthoquinonesantifungalantifungal agentscatnaphthoquinoneSporothrix spp.sporotrichosiszoonosis

Identifiers

PMID34152816
PMCPMC8370232
OpenAlexW3174538709

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.